Financial statements Artespharm

Balance sheet of Artespharm

Company age:
Age:
10 y. 4 m. 4 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of ARTESPHARM

Year
2018
2019
2020
Total assets 1 869 068,44 1 244 563,13 1 075 093,38
A. Fixed assets 473 288,45 412 211,91 312 629,34
B. Current assets 1 395 779,99 832 351,22 762 464,04
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 1 869 068,44 1 244 563,13 1 075 093,38
A. Equity -5 324 649,17 -5 901 013,45 -6 796 513,95
B. Liabilities and provisions for liabilities 7 193 717,61 7 145 576,58 7 871 607,33
I. Long-term liabilities 5 428 163,35 5 947 444,47 6 635 180,59
II. Short-term liabilities 1 765 554,26 1 198 132,11 1 236 426,74
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.